Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

OBJECTIVE: To report initial results of a planned multicenter year‐long prospective study examining the risk and impact of COVID‐19 among persons with neuroinflammatory disorders (NID), particularly multiple sclerosis (MS). METHODS: In April 2020, we deployed online questionnaires to individuals in...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin, Seth N., Venkatesh, Shruthi, Nelson, Katie E., Li, Yi, Aguerre, Ines, Zhu, Wen, Masown, Karman, Rimmer, Kathryn T., Diaconu, Claudiu I., Onomichi, Kaho B., Leavitt, Victoria M., Levine, Libby L., Strauss‐Farber, Rebecca, Vargas, Wendy S., Banwell, Brenda, Bar‐Or, Amit, Berger, Joseph R., Goodman, Andrew D., Longbrake, Erin E., Oh, Jiwon, Weinstock‐Guttman, Bianca, Thakur, Kiran T., Edwards, Keith R., Riley, Claire S., Xia, Zongqi, De Jager, Philip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013889/
https://www.ncbi.nlm.nih.gov/pubmed/33616290
http://dx.doi.org/10.1002/acn3.51314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013889/
https://www.ncbi.nlm.nih.gov/pubmed/33616290
http://dx.doi.org/10.1002/acn3.51314

Ejemplares similares